Your browser doesn't support javascript.
loading
ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate Cancer.
Lev, Avital; Lulla, Amriti R; Ross, Brian C; Ralff, Marie D; Makhov, Petr B; Dicker, David T; El-Deiry, Wafik S.
Afiliação
  • Lev A; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Lulla AR; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Ross BC; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Ralff MD; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Makhov PB; Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Dicker DT; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • El-Deiry WS; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. wafik.eldeiry@fccc.edu.
Mol Cancer Res ; 16(5): 754-766, 2018 05.
Article em En | MEDLINE | ID: mdl-29588330

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Receptores Androgênicos / Antígeno Prostático Específico / Everolimo / Compostos Heterocíclicos de 4 ou mais Anéis / Antineoplásicos Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Receptores Androgênicos / Antígeno Prostático Específico / Everolimo / Compostos Heterocíclicos de 4 ou mais Anéis / Antineoplásicos Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article